Psyence Biomedical

PBM · NASDAQ

$4.17+$0.045 (+1.09%)TodayMarket closed ·
Prev close $4.12

Latest news

  • News

    Psyence Biomedical Completes Its Additional Investment In PsyLabs Of $2,599,896

  • Press releaseGlobe Newswire

    Psyence BioMed Completes PsyLabs Investment as Ibogaine Milestones Are Met

  • News

    Psyence Biomedical Signs Manufacturing Services Agreement With DEA-Registered Benuvia For Planned U.S. Manufacture Of Pharmaceutical-Grade Ibogaine Active Pharmaceutical Ingredient

  • Press releaseGlobe Newswire

    Psyence BioMed Partners with DEA-Registered Benuvia Operations to Establish U.S. Manufacture of Pharmaceutical-Grade Ibogaine

  • News

    Psyence Biomedical Unit TIRC Signs Binding Term Sheet With Psyence Labs For An Exclusive License, Supply And Wholesale Distribution Arrangement For Psylabs’ Pharmaceutical-Grade Ibogaine In The U.S.

  • Press releaseGlobe Newswire

    Psyence BioMed Announces Exclusive U.S. Ibogaine Licence for Texas Ibogaine Research Corporation

  • News

    Psyence Biomedical Agrees To Make Cash Investment Of Up To $5M In Psyence Labs

  • Press releaseGlobe Newswire

    Psyence BioMed Announces Strategic Ibogaine Investment

  • Press releaseGlobe Newswire

    Psyence BioMed Establishes Texas Ibogaine Research Corporation to Advance U.S. Ibogaine Development

  • Press releaseGlobe Newswire

    Psyence BioMed Welcomes U.S. Administration’s Latest Action to Accelerate Ibogaine Development

  • News

    12 Health Care Stocks Moving In Tuesday's Pre-Market Session

  • News

    12 Health Care Stocks Moving In Tuesday's Intraday Session

  • News

    12 Health Care Stocks Moving In Wednesday's After-Market Session

  • News

    12 Health Care Stocks Moving In Friday's Pre-Market Session

  • News

    12 Health Care Stocks Moving In Wednesday's Intraday Session

  • News

    12 Health Care Stocks Moving In Wednesday's Pre-Market Session

  • NewsKaustubh Bagalkote

    Why Is Psyence Biomedical Stock Falling Wednesday?

  • News

    12 Health Care Stocks Moving In Monday's Intraday Session

  • NewsHenry Khederian

    PBM Jumps On Trump Psychedelic Push, Ibogaine Supply Story

  • NewsAvi Kapoor

    Dow Jumps Over 600 Points; Netflix Shares Tumble After Q1 Results

  • News

    12 Health Care Stocks Moving In Thursday's Intraday Session

  • News

    'Trump To Sign Executive Order On Psychedelic Drug Used Abroad To Treat PTSD' - CBS News Exclusive

  • News

    12 Health Care Stocks Moving In Friday's Pre-Market Session

  • News

    12 Health Care Stocks Moving In Tuesday's Pre-Market Session

  • Press releaseGlobe Newswire

    From Super Fibers to Super Deals: Science, Scale, and Strategic Capital Shape the Morning Tape

  • News

    Market-Moving News for December 19th

  • News

    12 Health Care Stocks Moving In Friday's Pre-Market Session

  • NewsAvi Kapoor

    Why Intuit Shares Are Trading Higher; Here Are 20 Stocks Moving Premarket

  • News

    12 Health Care Stocks Moving In Thursday's Intraday Session

  • News

    12 Health Care Stocks Moving In Thursday's Pre-Market Session

  • NewsAvi Kapoor

    Why Bullish Shares Are Trading Higher By 12%; Here Are 20 Stocks Moving Premarket

  • News

    12 Health Care Stocks Moving In Monday's Intraday Session

  • NewsAvi Kapoor

    Dow Jumps 1%; Tyson Foods Earnings Beat Views

  • NewsAvi Kapoor

    Why CommScope Shares Are Trading Higher By Around 40%; Here Are 20 Stocks Moving Premarket

  • NewsHenry Khederian

    Psyence BioMed (PBM) Shares Soar On Ibogaine Production Breakthrough

  • NewsAvi Kapoor

    Nasdaq Surges Over 1%; Microsoft Posts Upbeat Earnings

  • News

    12 Health Care Stocks Moving In Tuesday's Intraday Session

  • Press releaseGlobe Newswire

    PSYENCE GROUP INC. Announces Update on Previously Announced Non-Brokered Private Placement of Common Shares

  • Press releaseGlobe Newswire

    PSYENCE GROUP INC. Announces Offering of up to C$600,000 Non-Brokered Private Placement of Common Shares

  • News

    12 Health Care Stocks Moving In Thursday's Pre-Market Session

  • NewsJuan Spínelli

    Psyence Biomedical Secures Extension To Meet Nasdaq Compliance Standards

  • Press releaseGlobe Newswire

    Psyence Biomedical Announces Favorable Result of Nasdaq Listing Qualifications Hearing

  • Press releaseGlobe Newswire

    Psyence Biomedical Announces Effective Date for 1-for-75 Share Consolidation

  • News

    12 Health Care Stocks Moving In Wednesday's Pre-Market Session

  • Press releaseGlobe Newswire

    Psyence Biomedical Announces Results from Annual and Special General Meeting, Share Consolidation and Receipt of Additional Staff Determination from Nasdaq

  • News

    12 Health Care Stocks Moving In Thursday's Intraday Session

  • News

    12 Health Care Stocks Moving In Thursday's Intraday Session

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.